Clinical Trial Update: Corticosteroids and Myocardial Injury in CAP (COLOSSEUM TRIAL) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on the use of corticosteroids to reduce myocardial injury in community-acquired pneumonia (COLOSSEUM TRIAL).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Community-acquired Pneumonia | Phase 3 | Status: UNKNOWN